‘A translation story: from the identification of a platelet receptor (GPVI) to the development of a drug candidate (glenzocimab) up to phase 2-3 clinical trials in acute ischemic stroke’
‘A translation story: from the identification of a platelet receptor (GPVI) to the development of a drug candidate (glenzocimab) up to phase 2-3 clinical trials in acute ischemic stroke’